Market Dynamics: The global market for cardiotoxicity is poised to exhibit a strong revenue compound annual growth rate (CAGR) in the forecast period. The growth in market revenue is primarily propelled by factors such as increasing awareness about heart health among individuals and a rise in healthcare expenditures by key industry players.
Opportunities: The growth of the cardiotoxicity market is driven by the introduction of new technologies to improve cardiovascular health and the development of safer treatment options. Additionally, increased research and development activities are contributing to the growth of market revenues.
The research’s goal is to enhance understanding of the pathophysiology and more accurately diagnose cardiac dysfunction in patients with chemotherapy-induced cardiotoxicity. Increasing research on CVCs associated with tailored therapy is a positive trend, with trastuzumab-induced heart damage being one example.
Market Share Insights: The North America region is projected to capture the largest share of revenue during the forecast period, primarily due to the increasing prevalence of cardiovascular diseases in the United States. Approximately 659,000 people die each year in the U.S. due to cardiovascular problems.
The Asia Pacific region is expected to experience the fastest growth during the forecast period, driven by an increase in the prevalence of heart disease and greater awareness. Improved healthcare infrastructure and increased research activities in the region are also contributing to market growth. Factors such as a rise in inflammatory diseases, a weakened immune system, an aging population, and the entry of significant new companies are further driving market growth.
Get a sample copy of the Cardiotoxicity Market report: https://www.reportsanddata.com/download-free-sample/5368
Cardiotoxicity refers to cardiac damage resulting from cancer treatment, particularly chemotherapy or targeted therapy medications. Patients who have been treated with certain chemotherapy or targeted therapy drugs are at a higher risk of developing cardiotoxicity. Individuals who have received chest radiation therapy are also susceptible. While some forms of cardiotoxicity can be reversed, others require ongoing care.
Key Factors Driving Market Growth: Drivers: The major factors fueling the growth of the cardiotoxicity market include the increasing prevalence of cancer, which was responsible for approximately 10 million deaths, or nearly one in six deaths, globally in 2020, making it the leading global cause of mortality.
The rising number of cancer survivors in various parts of the world has ignited research in cardio-oncology. This research is expected to reduce the prevalence of concurrent cardiovascular disorders in the population, making the growth of the cardiotoxicity market significant for oncologists worldwide. They are focusing on evaluating the relationship between life-threatening cardiovascular diseases and life-saving chemotherapies. Ischemia, rhythm disorders, and left ventricular failure are significant forms of cardiotoxicity.
The anticipated increase in the prevalence of cardiotoxicity is expected to boost the global market for this condition. Furthermore, the adoption of targeted anticancer medications, the proliferation of healthcare facilities, a growing demand for safer treatments by patients, and active participation in research and development efforts by market players are all contributing to the expansion of market revenues.
Firms are currently assessing potential cardiovascular complications associated with the recommended chemotherapies, such as Central Venous Catheter (CVC). Cancer patients undergoing extended chemotherapy regimens have been experiencing issues related to CVCs and other risk factors. Several regulatory authorities have emphasized the main risk factors for chemotherapy-induced cardiotoxicity, including coronary artery disease, arrhythmias, and thromboembolic disorders.
Market revenue growth is also driven by factors such as increased spending on research and development to create more effective medications and a higher incidence of cardiovascular disorders.
Key Market Trends and Innovations: A trend towards new drugs and combination treatments is gaining traction in the cardiotoxicity market.
Studies are being conducted on the prevention of cardiotoxicity in patients with systemic breast cancer through the combination of sacubitril and valsartan at the Regional Cancer Centre in Opole, Poland.
Major Companies in the Market Include:
- Medtronic
- St. Jude Medical
- Liva Nova
- Cardinal Health Inc.
- Abbott
- Johnson & Johnson
- Terumo Cardiovascular Systems Corporation
- Becton Dickinson Company
- Boston Scientific Corporation
- Biotronik
Scope of the Report: The report covers various aspects, including disease type, drugs type, route of administration, product type, distribution channel, and end-user outlook. It provides insights into market revenue forecasts from 2019 to 2030 for each of these categories. Regional outlooks are also provided, encompassing North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Explore Trending Reports:
Medical Polytetrafluoroethylene (PTFE) Market-https://www.globenewswire.com/news-release/2019/03/26/1768584/0/en/Medical-Polytetrafluoroethylene-PTFE-Market-To-Reach-USD-504-24-Million-By-2026.html
Subsea Thermal Insulation Materials Market-https://www.globenewswire.com/news-release/2019/05/21/1833664/0/en/Subsea-Thermal-Insulation-Materials-Market-To-Reach-USD-107-9-Million-by-2026-Reports-And-Data.html
Plastic To Fuel Technology Market-https://www.globenewswire.com/news-release/2019/07/18/1884734/0/en/Plastic-To-Fuel-Technology-Market-To-Reach-USD-2-33-Billion-By-2026-Reports-And-Data.html
Medical Tubing Market-https://www.globenewswire.com/news-release/2019/08/12/1900495/0/en/Medical-Tubing-Market-To-Reach-USD-12-50-Billion-By-2026-Reports-And-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5368
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
